RPG Life Sciences Limited

₹1,874.4-1.83%Feb 27, 3:45 PM IST

RPGLIFE•Health Technology•Pharmaceuticals: Major

Current Price

₹1,874.4-1.83%

Feb 27, 3:45 PM IST

Market Cap₹3,160.44 Cr

Business Overview

RPG LIFE SCIENCES LIMITED operates through 3 main business divisions including Domestic Formulations, International Formulations, APIs (Active Pharmaceutical Ingredients / Bulk Drugs).

Business Hierarchy Structure for RPG LIFE SCIENCES LIMITED

RPG LIFE SCIENCES LIMITED
- Domestic Formulations
  - Segments
    - Mass
    - Mass Specialty
    - Specialty
  - Key Brands
    - Immunosuppressant Brand Portfolio
      - Azoran
      - Mofetyl
      - Arpimune ME
      - Imunotac
    - Textbook Brand Portfolio
      - Azoran
      - Aldactone
      - Naprosyn +
      - Lomotil
      - Norpace New
      - Serenace
  - New Brand Portfolio - Specialty
    - HerMab
    - Adlumab
    - Ivzumab
    - Zestmab
    - Denbri
    - T-JAKI
    - TPT 20
    - Igurnorm™
    - IroHigh
    - FC-IRO
    - Fulbreca
    - Palbøpro
    - Eltoplate
    - Enuta
    - Octlect 30
    - TAXOCAB
    - AZOPEN O
    - Caspifung
    - RIVORCA
  - New Brand Portfolio - Chronic
    - NuGliptin
    - GliptiNext
    - DPO
    - TAMFLO DFZ
    - Mirasmart s
    - Solifirst
    - DebruMab
    - ROZITAZ10
    - Glimetop
    - SacuNew
    - RPTEL
    - TeriStrong
    - Tofuma
    - Prebaneuro
  - Therapy-wise Product Portfolio
    - Specialties
      - Nephrology
        Azoran
        Irohigh
        Mofetyl
        RPO
        Alfalog
      - Rheumatology
        Adlumab
        T-Jaki
        TPT
        Igurnorm
        Darba
        Imunotac
        FC-IRO
        Xmab
      - Oncology
        Hermab
        Enuta
        Ivzumab
        Eltoplate
        Zestmab
        Fulbreca
        Zpac
        Densurank
        OctJet
        Taxocab
        Azopen
        Caspifung
        Palbopro
        Rivorca
      - Gastroenterology
        Adlumab
        T-Jaki
        Azoran
        Mofetyl
    - Mass/Mass Specialties
      - Cardiology
        Aldactone
        Rptel
        Norpace
        Rozitaz
        Cardibeta
      - Diabetology
        Nugliptin
        Gliptinext
        DPO
        Glimetop
      - Neuropsychiatry
        Serenace
      - Respiratory
        Romilast
        Daslin
      - Nutritional
        Nutrikit
        Minmin
      - Urology
        Irorain
        Sildura
        Mirasmart
        Tamflo
        Abitate
      - Gastroenterology
        Lomotil
        Tricaine
        Lomofen +
        Lomofen LB
    - Orthopedics
      - Naprosyn
      - Minmin D3
      - Rabee
      - Debrumab
      - Teristrong
      - Tofuma
      - Prebaneuro
- International Formulations
  - Product Categories
    - Generics
    - Branded Generics
  - Generics
    - Azathioprine
    - Sodium Valproate
    - Nicorandil
    - Sertraline
  - Branded Generics
    - Nephrology (Immunosuppressant)
      - Azoran
      - Mofetyl
      - Arpimune
    - Gastrointestinal
      - Siloxogene
      - Tricaine MPS
    - Cardiovascular and Metabolic Disorders
      - Dipsope
      - Diasafe
      - Losatec
      - Serformin
  - Business Build-up Pillars
    - Build Immunosuppressant Portfolio
      - Azathioprine
      - Mycophenolate Mofetil
      - Tacrolimus
      - Cyclosporine
    - Focus on Products with Specific/Competitive Advantage
      - Complex Generic Product
      - Products needing Special Manufacturing Conditions
      - Low Competitive Intensity Products
    - Expand Footprints in Emerging Markets
      - Myanmar
      - Vietnam
      - Philippines
      - Thailand
      - Sri Lanka
      - Egypt
      - Sudan
      - South Africa
- APIs (Active Pharmaceutical Ingredients / Bulk Drugs)
  - Key Products
    - Immunosuppressant basket
      - Azathioprine
      - Mycophenolate Mofetil
    - Others
      - Quinfamide
      - Nicorandil
      - Haloperidol
      - Risperidone
      - Propantheline Bromide
      - Pantoprazole
      - Diphenoxylate
      - Lamotrigine
      - Sertraline
  - Manufacturing Facilities
    - MF2: Dedicated Immunosuppressant facility catering to Regulated Markets
    - MF3: Multipurpose unit catering to Regulated Markets
    - MF4: Multipurpose unit catering to Emerging Markets including India